The cost-effectiveness of primary stroke centers for acute stroke care

Stroke

Volumn 43, Issue 6, 2012, Pages 1617-1623

  Guzauskas, Gregory F ^a   Boudreau, Denise M ^a,b   Villa, Kathleen F ^c   Levine, Steven R ^d   Veenstra, David L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c GENENTECH INC   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

cost effectiveness; critical care; outcome research; quality of life; stroke center; thrombolytic therapy

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN ISCHEMIA; CAUSE OF DEATH; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PRIMARY STROKE CENTER; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REIMBURSEMENT;

AMBULATORY CARE FACILITIES; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; QUALITY OF LIFE; STROKE;

EID: 84861630172     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.648238     Document Type: Article

References (20)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: A report from the American heart association. Circulation. 2010;121:948-954.
2. Elkins JS, Johnston SC. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke. 2003;34:2109-2112.
3. Alberts MJ. Stroke centers: proof of concept and the concept of proof. Stroke. 2010;41:1100-1101.
4. The Joint Commission. Advanced Certification for Primary Stroke Centers. http://www.jointcommission.org/certification/primary
5. Alberts MJ. Preventing death one stroke at a time. JAMA. 2011;305: 408-409.
6. O'Toole LJ, Slade CP, Brewer GA, Gase LN. Barriers and facilitators to implementing primary stroke center policy in the United States: results from 4 case study states. Am J Public Health. 2011;101:561-566.
7. Fonarow GC, Gregory T, Driskill M, Stewart MD, Beam C, Butler J, et al. Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes. Circulation. 2010;122:2459-2469.
8. Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, et al. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011;305:373-380.
9. Demaerschalk BM, Hwang HM, Leung G. Cost analysis review of stroke centers, telestroke, and rt-PA. Am J Manag Care. 2010;16:537-544.
10. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
11. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP, American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945-2948.
12. Wilson JT, Hareendran A, Hendry A, Potter J, Bone I, Muir KW. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke. 2005;36:777-781.
13. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007;4:CD000197.
14. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 1998;50: 883-890.
15. Samsa GP, Reutter RA, Parmigiani G, Ancukiewicz M, Abrahamse P, Lipscomb J, et al. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol. 1999;52: 259-271.
16. Pervez MA, Silva G, Masrur S, Betensky RA, Furie KL, Hidalgo R, et al. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke. 2010;41:e18-e24.
17. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ. The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology. 2011;77:1590-1598.
18. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
19. Gropen TI, Gagliano PJ, Blake CA, Sacco RL, Kwiatkowski T, Richmond NJ, et al. Quality improvement in acute stroke: The New York State Stroke Center Designation Project. Neurology. 2006;67: 88-93.
20. Stradling D, Yu W, Langdorf ML, Tsai F, Kostanian V, Hasso AN, et al. Stroke care delivery before vs after JCAHO stroke center certification. Neurology. 2007;68:469-470.